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Background: Chronic obstructive pulmonary disease (COPD) is a known predictor of
decreased long-term survival after coronary artery bypass grafting (CABG). Differences
in survival by race have not been examined.
Methods: A retrospective cohort study was conducted of CABG patients between 2002
and 2011. Long-term survival was compared in patients with and without COPD and strat-
ified by race. Hazard ratios (HR) and 95% confidence intervals (CI) were computed using
a Cox regression model.
Results:A total of 984 (20%) patients had COPD (black n=182; white n= 802) at the time
of CABG (N =4,801).The median follow-up for study participants was 4.4 years. COPD was
observed to be a statistically significant predictor of decreased survival independent of race
following CABG (no COPD: HR=1.0; white COPD: adjusted HR=1.9, 95% CI=1.7–2.3;
black COPD: adjusted HR=1.6, 95% CI=1.1–2.2).
Conclusion: Contrary to the expected increased risk of mortality among black COPD
patients in the general population, a similar survival disadvantage was not observed in
our CABG population.
Keywords: COPD, CABG, survival, long-term, race
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) affects an esti-
mated 15 million Americans and is an important predictor of
mortality following coronary artery bypass grafting (CABG) (1–
4). The prevalence of COPD among CABG patients varies from
11 to 25.8% (1, 2, 4). COPD recently has become the third leading
cause of death in the United States (5). Risk factors potentially
associated with cardiovascular disease and COPD include history
of smoking, increasing age, exposure to air pollution, and lower
socioeconomic position, with smoking being the lead risk factor
(6, 7). Between 1980 and 2000, COPD death rates increased by
67% in whites and 87% in blacks even though COPD is more
prevalent in whites (6).
Survival paradoxes are well-documented in the cardiovascular
literature. Conventional cardiovascular risk factors such as black
race, hypercholesterolemia, hypertension, and obesity are asso-
ciated with increased survival among some patient populations
(8, 9). For example, a recent examination of the national Soci-
ety of Thoracic Surgeons (STS) Adult Cardiac Surgery Database
reported a survival advantage among obese patients after CABG
compared with non-obese patients (9).
The rationale for the current study was to determine if sim-
ilar reverse epidemiologic findings are observed among black
COPD patients undergoing isolated CABG in our rural, racially
dichotomous population. Consistent with the expected force
of mortality among blacks, we hypothesized that white COPD
patients would have better long-term survival than black COPD
patients (6).
MATERIALS AND METHODS
STUDY DESIGN
This was a retrospective cohort study of patients undergoing first-
time, isolated CABG at the East Carolina Heart Institute between
2002 and 2011. Demographic data, comorbid conditions, coro-
nary artery disease (CAD) severity, and surgical data were collected
at the time of surgery. Patients with COPD were compared with
those without COPD. Only black and white patients were included
to minimize the potential for residual confounding (∼1% other
races). Racial identity was self-reported. Emergent cases were con-
sidered a clinically different population with a different etiology
following surgery and were excluded in our analysis (n= 105).
The study was approved by the Institutional Review Board at the
Brody School of Medicine, East Carolina University.
DEFINITIONS
COPD was classified based on severity using the following criteria
at the time of surgery: Mild: FEV1 60–75% of predicted, and/or on
chronic inhaled or oral bronchodilator therapy; Moderate: FEV1
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50–59% of predicted, and/or on chronic steroid therapy aimed
at lung disease; Severe: FEV1< 50% predicted, and/or room air
pO2 < 60 or room air pCO2 > 50. Mortality was defined as any
cause of death postoperatively. CAD was defined as at least 50%
stenosis and confirmed by angiography before surgery.
SETTING
The East Carolina Heart Institute is a 120-bed cardiovascular
hospital located in the center of eastern North Carolina, a rural
region with a large black population. Cardiovascular disease is the
number one cause of death in North Carolina with an unequal
burden occurring in eastern North Carolina (10). The institute
is a population-based tertiary referral center. Nearly all patients
treated at the East Carolina Heart Institute live and remain within
a 150 mile radius of the medical center.
DATA COLLECTION AND FOLLOW-UP
The primary sources of data extraction were the STS Adult Cardiac
Surgery Database and the electronic medical record at the Brody
School of Medicine.
Cardiovascular surgery information at our facility has been
reported to the STS since 1989. Data quality and cross-field valida-
tion are routinely performed by the Epidemiology and Outcomes
Research Unit at the East Carolina Heart Institute. An electronic
medical record was introduced at the Brody School of Medicine
in 1997. Local and regional clinics were consolidated under a sin-
gle electronic medical record in 2005 which allowed for efficient
patient follow-up. The electronic medical record system applies
multiple logic comparisons to reliably reduce mismatching of
patient data across clinics and follow-up visits. The STS database
is linked to the electronic medical record through a unique patient
medical record number. COPD status was not collected in our
database prior to 2002.
The National Death Index was used to obtain death dates for
patients lost to follow-up and also used to validate death informa-
tion captured in our electronic medical record (11–13). Linkage
with the National Death Index was based on a multiple criteria,
deterministic matching algorithm (13). In our database, less than
5% of validated deaths failed to correctly match with the National
Death Index.
STATISTICAL ANALYSIS
Categorical variables were reported as frequency and percent-
age while continuous variables were reported as mean± standard
deviation, median, and range. Variables not previously categorized
were divided into quartiles prior to statistical analysis. Quartile
categorization is advantageous because it limits the influence of
outliers and allows for the assessment of trend across categories.
Follow-up time was measured from the date of surgery to the
date of death or censoring. Survival probabilities were computed
using the Kaplan–Meier product limit method and stratified by
COPD and race. The log-rank test was used to compare sur-
vival between patients with and without COPD and among COPD
patients by race. Cox proportional hazard regression models were
used to compute hazard ratios (HR) and 95% confidence inter-
vals (CI) for long-term mortality. The initial multivariable models
included variables that have been previously reported to be asso-
ciated with cardiovascular-related mortality, regardless of their
statistical significance in our dataset. These included age, sex,
race, hypertension, CAD severity, congestive heart failure (CHF),
and prior stroke. The post hoc addition of other variables into
the model was performed in a pairwise fashion. The test statistic
of Grambsch and Therneau was used to check the proportional
hazards assumption (14). Statistical significance for categorical
variables was tested using the chi-square (χ2) method and the
Kruskal–Wallis procedure for continuous variables. PTrend was
computed using a likelihood ratio test. Temporality during the
study period was assessed by stratifying the analysis by two time
periods.
Few values were missing (<1% for included variables). How-
ever, when values were missing they were entered into the regres-
sion models as a separate category. A sensitivity analysis with
missing values excluded also was performed to confirm that
model beta coefficients did not substantively differ from the above
results.
Statistical significance was defined as p< 0.05. SAS Version 9.3
(Cary, NC, USA) was used for all analyses.
RESULTS
A total of 984 (20%) patients had COPD (black n= 182; white
n= 802) at the time of CABG (N = 4,801). The prevalence of
COPD was higher in white vs. black patients (21 vs. 18%)
(p< 0.05). The severity of COPD among black vs. white patients,
defined as none, mild, moderate/severe, was not statistically dif-
ferent (p= 0.10). Patient characteristics are described in Table 1.
The median follow-up for study participants was 4.4 years.
COPD patients had a lower body mass index (BMI)
(mean= 29± 6.0 vs. 30± 5.5; p< 0.01) and were more likely to be
white (82 vs. 78%; p< 0.05) than non-COPD patients. On admis-
sion, COPD patients were more likely to have left main disease
(31 vs. 25%), hypertension (86 vs. 82%), CHF (35 vs. 23%), renal
failure (4 vs. 2%), peripheral arterial disease (PAD) (26 vs. 13%),
previous myocardial infarction (MI) (55 vs. 47%), and previous
stroke (11 vs. 8%) (p< 0.01). COPD patients also were more likely
to be recent smokers (55 vs. 26%) and have non-elective CABG
(57 vs. 50%) (p< 0.01).
Kaplan–Meier unadjusted survival curves are shown in
Figure 1. The 5-year survival for patients with and without COPD
was 73 and 87%, respectively (p< 0.0001). The 5-year survival for
black and white COPD patients was similar (73%).
The unadjusted HR for COPD was 2.1 (95% CI= 1.8–2.4)
compared with no COPD. After adjusting for age, sex, race, hyper-
tension, CAD severity, CHF, and prior stroke, the HR decreased
to 1.9 (95% CI= 1.6–2.2). COPD was observed to be a statis-
tically significant predictor of decreased survival independent of
race following CABG (no COPD: HR= 1.0; white COPD: adjusted
HR= 1.9,95% CI= 1.7–2.3; black COPD: adjusted HR= 1.6,95%
CI= 1.1–2.2) (Table 2). The multivariable results did not substan-
tively change with the pairwise addition of other variables listed
in Table 1.
DISCUSSION
The significantly increased risk of mortality among COPD patients
after CABG in our study (adjusted HR= 1.9, 95% CI= 1.6–2.2)
is consistent with previous reports (1, 2, 4). A review of 33,137
Frontiers in Public Health | Epidemiology April 2013 | Volume 1 | Article 4 | 2
Efird et al. COPD and survival after CABG
Table 1 | Patients characteristics and univariable survival after CABG (N =4,801).
Characteristic No COPD n (%) COPD Univariable HR (95% CI)
Black n (%) White n (%)
Overall 3,817 (80) 182 (4) 802 (16) 2.1 (1.8–2.4)§
Age (years)
Q1 (≤56) 987 (26) 53 (29) 178 (22) 1.0 Referent
Q2 (>56–64) 995 (26) 43 (24) 223 (28) 1.5 (1.1–1.9)
Q3 (>64–72) 998 (26) 46 (25) 218 (27) 2.3 (1.9–2.9)
Q4 (>72) 837 (22) 40 (22) 183 (23) 3.9 (3.2–4.9)
Mean±SD, median (range) 64±10, 64 (26–90) 63±10, 63 (33–85) 64±10, 65 (31–89) PTrend <0.0001
Sex
Male 2,723 (71) 117 (64) 595 (74) 1.0 Referent
Female 1,094 (29) 65 (36) 207 (26)
†
1.3 (1.1–1.5)
Race
White 2,967 (78) – – 1.0 Referent
Black 850 (22) – – 1.2 (1.03–1.4)
BMI (kg/m2)*
Obese (≥30) 1,716 (45) 78 (43) 314 (39) 1.0 Referent
Overweight (25–29.9) 1,461 (38) 64 (35) 268 (33) 1.3 (1.1–1.5)
Normal (18.5–24.9) 622 (16) 34 (19) 204 (25) 1.8 (1.5–2.2)
Underweight (<18.5) 18 (<1%) 6 (3) 16 (2)
††
2.5 (1.4–4.4)
Mean±SD, median (range) 30±5.7, 29 (13–66) 29±6.3, 29 (17–53) 29±6.0, 28 (15–51)†† PTrend <0.0001
Status
Elective 1,908 (50) 73 (40) 351 (44) 1.0 Referent
Non-elective 1,908 (50) 109 (60) 451 (56)
††
1.2 (1.04–1.4)
CAD severity
1 Vessel 268 (7) 10 (5) 41 (5) 1.0 Referent
2 Vessel 971 (25) 41 (23) 218 (27) 1.6 (1.1–2.4)
3 Vessel 2,578 (68) 131 (72) 543 (68) 1.9 (1.4–2.8)
PTrend <0.0001
Left main disease
No 2,870 (75) 127 (70) 555 (69) 1.0 Referent
Yes 947 (25) 55 (30) 247 (31)
††
1.1 (0.93–1.3)
Recent smoker
No 2834 (74) 85 (47) 362 (45) 1.0 Referent
Yes 983 (26) 97 (53) 440 (55)
††
0.98 (0.85–1.1)
Hypertension
No 680 (18) 16 (9) 122 (15) 1.0 Referent
Yes 3,137 (82) 166 (91) 680 (85)
††
1.4 (1.2–1.7)
Diabetes
No 2,309 (60) 94 (52) 490 (61) 1.0 Referent
Yes 1,508 (40) 88 (48) 312 (39) 1.4 (1.3–1.7)
Congestive heart failure
No 2,927 (77) 107 (59) 532 (66) 1.0 Referent
Yes 890 (23) 75 (41) 270 (34)
††
2.1 (1.9–2.5)
Renal failure
No 3,744 (98) 175 (96) 771 (96) 1.0 Referent
Yes 73 (2) 7 (4) 31 (4)
††
4.2 (3.2–5.6)
Dialysis
No 3,730 (98) 165 (91) 793 (99) 1.0 Referent
Yes 87 (2) 17 (9) 9 (1)
††
4.9 (3.7–6.4)
(Continued)
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Table 1 | Continued
Characteristic No COPD n (%) COPD Univariable HR (95% CI)
Black n (%) White n (%)
Peripheral arterial disease
No 3,320 (87) 136 (75) 590 (74) 1.0 Referent
Yes 497 (13) 46 (25) 212 (26)
††
2.1 (1.8–2.5)
Prior MI
No 2,007 (53) 77 (42) 367 (46) 1.0 Referent
Yes 1,810 (47) 105 (58) 435 (54)
††
1.5 (1.3–1.7)
Prior stroke
No 3,509 (92) 157 (86) 719 (90) 1.0 Referent
Yes 308 (8) 25 (14) 83 (10)
††
1.8 (1.5–2.3)
Prior PCI
No 2,876 (75) 135 (74) 619 (77) 1.0 Referent
Yes 941 (25) 47 (26) 183 (23) 0.83 (0.70–0.98)
†p< 0.05; ††p<0.01; χ2 (Categorical variables), Kruskal–WallisTest (Continuous variables). *Missing category not shown. §COPD vs. no COPD. BMI, body mass index;
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; MI,
myocardial infarction; PCI, percutaneous coronary intervention; Q1, quartile 1; Q2, quartile 2; Q3, quartile 3; Q4, quartile 4.
FIGURE 1 | CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease.
CABG cases from hospitals in northern New England found
COPD to be an independent predictor of decreased long-term
survival (HR= 1.8, 95% CI= 1.6–2.1) (1). A covariate-matched
analysis of 3,760 patients in New York that underwent isolated
CABG similarly found an increased risk in long-term mortal-
ity for patients with COPD (HR= 1.28, 95% CI= 1.11–1.47)
(2). Furthermore, a review of 13,337 CABG procedures in the
United Kingdom found COPD to be a predictor of long-term
survival and differences were noted between moderate (HR= 1.3,
95% CI= 1.1–1.5) and severe (HR= 1.9, 95% CI= 1.5–2.4) cases
(4). Our results also are comparable with population-based data
showing that COPD is a predictor of mortality in the gen-
eral population and that COPD is more prevalent in white
patients (6, 15).
Death rates have been reported to be higher among black vs.
white COPD patients, reflecting a greater force of mortality among
blacks in the general population (6, 16). A recent examination
of the national lung transplant list observed that black COPD
patients died sooner than whites; however, the results were con-
founded by patients who were removed from the transplant list
(17). In contrast, the HR for the black COPD arm in our study
was in the reverse direction, being less than white COPD. In a
comparable analysis of patients without COPD, an increased force
of mortality was observed among black PAD patients (no PAD,
HR= 1.0; white PAD: adjusted HR= 1.4, 95% CI= 1.1–1.8; black
PAD: adjusted HR= 2.1, 95% CI= 1.5–3.0). The latter highlights
a clear force of mortality among black patients for another chronic
disease population at-risk for cardiovascular disease and empha-
sizes the unexpected finding among black COPD patients in our
study.
Survival paradoxes in black patients are well-documented in
the literature (18–21). Our data showed no survival advantage
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Table 2 | Multivariable survival after CABG.
Characteristic Multivariable HR (95% CI)
Main effect
No COPD 1.0 Referent
Black COPD 1.6 (1.1–2.2)
White COPD 1.9 (1.7–2.3)
Age (years)
Q1 (≤56) 1.0 Referent
Q2 (>56–64) 1.4 (1.1–1.8)
Q3 (>64–72) 2.2 (1.7–2.7)
Q4 (>72) 3.5 (2.8–4.3)
PTrend < 0.0001
Sex
Male 1.0 Referent
Female 1.1 (0.92–1.2)
CAD severity
1 Vessel 1.0 Referent
2 Vessel 1.4 (0.97–2.1)
3 Vessel 1.5 (1.1–2.2)
PTrend=0.017
Hypertension
No 1.0 Referent
Yes 1.2 (1.02–1.5)
Congestive heart failure
No 1.0 Referent
Yes 1.8 (1.6–2.1)
Prior stroke
No 1.0 Referent
Yes 1.5 (1.3–1.9)
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CI, con-
fidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard
ratio.
for white COPD patients and a survival paradox for black
COPD patients cannot be ruled out. Contrary to our hypoth-
esis, a statistically significant survival disadvantage was not
observed among black patients in our CABG population. How-
ever, uncertainty remains due to the limited number of patients
at-risk toward the end of the study. A possible explanation
for our discordant findings may involve differences in lung
function and susceptibility to tobacco smoke between black
and white COPD patients (22, 23). Also, differences in the
response to standard COPD therapies could exist between
races (24).
STRENGTHS AND LIMITATIONS
Our study is strengthened by its comparatively large sample size
and long-term follow-up. To the best of our knowledge, this is
the largest study to date examining survival differences among
COPD CABG patients by race. Furthermore, we were able to
accurately determine time of death using a combination of the
National Death Index and our comprehensive electronic medical
record.
Another strength of this study is its target base. A large pri-
ority population in eastern North Carolina allowed for us to
report on a group that has experienced historic differences in
socioeconomic position and discrimination. Twenty-eight (97%)
of the 29 counties in eastern North Carolina fall below the national
per capita income of $27,915, with half reporting a value less than
$20,000 (25). Similarly, 90% of the counties have a higher percent-
age of blacks than the national value of 13.1% (25). Our results
are generalizable to other low-income, rural, and racially diverse
populations.
Pulmonary function tests were not repeated prior to surgery.
Accordingly, there may have been misclassification of COPD sta-
tus between patients. We were unable to stratify our analyses by
COPD severity and race because of a limited number of patients.
Survival after CABG among COPD patients has been shown to
vary by disease severity and racial differences could exist across
the COPD severity spectrum (4).
Socioeconomic position, education, and income were not col-
lected and these factors may have influenced survival (26). Payor
status, which has been shown in some studies to predict survival
independent of race, was not consistently collected and conse-
quently was not used in our analysis (27). Additionally, we were
unable to reliably estimate socioeconomic position using zip codes
because a large percentage of patients in our catchment area live
in rural areas with postal box addresses.
Patients in this study were recruited over a relatively long
period (10 years), over which practice methods and clinical care
may have changed considerably. However, results were consis-
tent throughout the study after stratifying by two time periods,
indicating the robustness of the data to temporal changes. The
status of several variables in our analysis may have changed
over time. We did not adjust for these variables in a time-
dependent manner due to their potential to be in the causal
pathway. Similarly, surgical complications and medication use
were not included in our analysis because of their time-dependent
status.
Cause of death is not recorded in the National Death Index and
COPD status may have been unrelated to their mortality. Although
we adjusted for known clinically relevant variables, we acknowl-
edge that other unmeasured factors could have influenced our
results due to the retrospective nature of this study. Retrospec-
tive studies also are susceptible to recall and selection bias. We
cannot rule out that the association between COPD and poor
survival is non-causal in nature and may be due to non-cardiac
causes unassociated with comorbidities or surgical procedures
such as exacerbations requiring hospitalizations (15). Addition-
ally, examining the right tail of the Kaplan–Meier curve (Figure 1),
it is observed that the number of individuals at-risk reduces to
a few patients after year 6. Probability estimates at these later
time points may not be reliable and must be interpreted with
caution.
We considered missing values to be a distinct category and
they were entered into the regression models as a separate cat-
egory rather than being imputed. Imputation methods require
data to be “missing at random” which is difficult to verify
given the sparseness and unknown distribution of the missing
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values (28, 29). We cannot rule out misclassification bias due
to grouping missing values into a distinct category although
such bias likely is trivial given the small number of miss-
ing values. Furthermore, we performed a complete case analy-
sis with missing values removed and this did not substantively
alter our results. We opted not to report the complete analy-
sis because this would have reduced power for our multi-
variable analysis. Removing values only from the multivariate
analysis also would have resulted in a different dataset being
analyzed.
Our use of quartile boundaries, while desirable for minimizing
the influence of outliers, may have yielded overly broad cate-
gories and the potential for residual confounding. However, the
substitution of continuous variables in our models did not mate-
rially alter results. Except for race, we did not examine interac-
tions among other clinically relevant variables included in our
dataset. Given the large number of potential multi-level interac-
tions involving the independent variables in our analyses, it is
difficult to interpret such effects. Furthermore, we did not use
regression-based tests for interaction because they are known
to have weak power and often fail to detect interactions when
they exist (30). Multivariable Cox regression models, rather than
propensity score matching, were used to control for confounding
because of potential “non-collapsibility bias” inherent to logistic
regression-based propensity scores and the possible loss of power
due to incomplete matching (31). Alternative methods such as
machine learning (e.g., random forest algorithm) may introduce
misspecification into the propensity score model due to the “black
box” nature of the algorithm that obscures the etiologic relation-
ship between predictors and outcome and were not used in the
current analysis (32, 33).
CONCLUSION
Contrary to the expected increased risk of mortality among black
COPD patients in the general population, a similar survival disad-
vantage was not observed in the current study. Future research is
needed to confirm our initial findings. Exploring the association
between preoperative conditions such as COPD and outcomes,
especially in the context of racial disparities in rural populations,
may help guide future decisions regarding appropriate clinical
follow-up and surgical referral.
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